Elizabeth Sapey

Liz’s interests span translational science, physiological testing and moving new or repurposed therapies into early phase clinical trials. Her translational science focuses on neutrophil biology, strongly implicated in ageing and COPD related tissue damage and poor bacterial clearance. She has developed assays to study cellular functions and has designed and led clinical trials to study the efficacy of new therapies on neutrophil functions and clinical outcomes using clinical samples to identify pathways of interest, creating a porous pipeline to focus drug development on areas most likely to deliver.